Adiponectin improves cardiomyocyte contractile fnction in db/db diabetic obese mice

Obesity

Volumn 17, Issue 2, 2009, Pages 262-268

  Dong, Feng ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ERN2 PROTEIN, MOUSE; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, MOUSE; LEPTIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PERK KINASE; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE R; PROTEIN SERINE THREONINE KINASE;

ANIMAL; ARTICLE; BLOOD; CELL CULTURE; DISEASE MODEL; DRUG EFFECT; ENDOPLASMIC RETICULUM; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART CONTRACTION; HEART MUSCLE CELL; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPONECTIN; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; EIF-2 KINASE; ENDOPLASMIC RETICULUM; INSULIN RECEPTOR SUBSTRATE PROTEINS; LEPTIN; MALE; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MICE; MICE, OBESE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OBESITY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-JUN;

MUS;

EID: 58849116697     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.545     Document Type: Article

References (33)

1. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 2002;105: 2923-2928.
2. Ren J, Sowers JR, Walsh MF, Brown RA. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol 2000;279: H1708-H1714.
3. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20: 1595-1599.
4. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257: 79-83.
5. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100: 2473-2476.
6. Yu JG, Javorschi S, Hevener AL et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002;51: 2968-2974.
7. Kishida K, Nagaretani H, Kondo H et al. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun 2003;306: 286-292.
8. Pajvani UB, Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003;278: 9073-9085.
9. Kozakova M, Muscelli E, Flyvbjerg A et al. Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab 2008;93: 2811-2818.
10. Pineiro R, Iglesias MJ, Gallego R et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 2005;579: 5163-5169.
11. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24: 29-33.
12. Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004;53: 123-129.
13. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14: 561-566.
14. Shibata R, Ouchi N, Ito M et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004;10: 1384-1389.
15. Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 2005;54(Suppl 2): S73-S78.
16. Toth A, Nickson P, Mandl A et al. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets 2007;7: 205-218.
17. Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004;306: 457-461.
18. Ozcan U, Yilmaz E, Ozcan L et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006;313: 1137-1140.
19. Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 2004;53: 3201-3208.
20. Dong F, Zhang X, Yang X et al. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J Endocrinol 2006;188: 25-36.
21. Sreejayan N, Lin Y, Hassid A. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism. Arterioscler Thromb Vasc Biol 2002;22: 1086-1092.
22. Shibata R, Izumiya Y, Sato K et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007;42: 1065-1074.
23. Shibata R, Sato K, Pimentel DR et al. Adiponectin protects against myocardial ischemia-reperfusion injury through. Nat Med 2005;11: 1096-1103.
24. Palanivel R, Fang X, Park M et al. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc Res 2007;75: 148-157.
25. Tao L, Gao E, Jiao X et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007;115: 1408-1416.
26. Kato MF, Shibata R, Obata K et al. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt. J Hypertens 2008;26: 1669-1676.
27. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008;93: 3357-3364.
28. Urano F, Wang X, Bertolotti A et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000;287: 664-666.
29. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2) terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000;275: 9047-9054.
30. Sykiotis GP, Papavassiliou AG. Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol Endocrinol 2001;15: 1864-1869.
31. Miyazaki T, Bub JD, Uzuki M, Iwamoto Y. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun 2005;333: 79-87.
32. Dong F, Ren J. Fidarestat improves cardiomyocyte contractile function in db/db diabetic obese mice through a histone deacetylase Sir2-dependent mechanism. J Hypertens 2007;25: 2138-2147.
33. Neumeier M, Weigert J, Buettner R et al. Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 2007;293: E965-E969.